Reshma P. Shetty - Oct 28, 2022 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
President, COO & Founder, Director, 10%+ Owner
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Stock symbol
DNA
Transactions as of
Oct 28, 2022
Transactions value $
-$2,117,394
Form type
4
Date filed
11/1/2022, 05:30 PM
Previous filing
Oct 28, 2022
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Sale -$523K -199K -0.85% $2.63 23.2M Oct 28, 2022 Direct F1
transaction DNA Class A Common Stock Sale -$523K -199K -0.85% $2.63 23.2M Oct 28, 2022 By Spouse F1
transaction DNA Class A Common Stock Sale -$535K -198K -0.85% $2.71 23M Oct 31, 2022 Direct F1
transaction DNA Class A Common Stock Sale -$535K -198K -0.85% $2.71 23M Oct 31, 2022 By Spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Remarks:

President, COO & Founder